Fennec Pharmaceuticals, Inc. (FENC)
11.74
+0.34
(+2.98%)
USD |
NASDAQ |
Aug 25, 16:00
11.74
0.00 (0.00%)
After-Hours: 16:33
Fennec Pharmaceuticals Price to Book Value : 9.691 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 9.410 |
| August 21, 2026 | 9.319 |
| August 20, 2026 | 9.369 |
| August 19, 2026 | 9.798 |
| August 18, 2026 | 9.798 |
| August 17, 2026 | 9.765 |
| August 14, 2026 | 9.674 |
| August 13, 2026 | 9.955 |
| August 12, 2026 | 9.765 |
| August 11, 2026 | 10.55 |
| August 10, 2026 | 9.030 |
| August 07, 2026 | 9.555 |
| August 06, 2026 | 8.948 |
| August 05, 2026 | 8.684 |
| August 04, 2026 | 8.345 |
| August 03, 2026 | 7.916 |
| July 31, 2026 | 7.900 |
| July 30, 2026 | 8.180 |
| July 29, 2026 | 7.966 |
| July 28, 2026 | 8.205 |
| July 27, 2026 | 8.428 |
| July 24, 2026 | 8.246 |
| July 23, 2026 | 8.378 |
| July 22, 2026 | 8.519 |
| July 21, 2026 | 8.576 |
| Date | Value |
|---|---|
| July 20, 2026 | 8.172 |
| July 17, 2026 | 8.667 |
| July 16, 2026 | 8.618 |
| July 15, 2026 | 8.750 |
| July 14, 2026 | 9.212 |
| July 13, 2026 | 8.874 |
| July 10, 2026 | 8.659 |
| July 09, 2026 | 8.510 |
| July 08, 2026 | 8.461 |
| July 07, 2026 | 8.667 |
| July 06, 2026 | 8.824 |
| July 02, 2026 | 8.832 |
| July 01, 2026 | 8.535 |
| June 30, 2026 | 8.874 |
| June 29, 2026 | 10.11 |
| June 26, 2026 | 10.10 |
| June 25, 2026 | 9.672 |
| June 24, 2026 | 9.535 |
| June 23, 2026 | 9.443 |
| June 22, 2026 | 8.737 |
| June 18, 2026 | 8.306 |
| June 17, 2026 | 8.233 |
| June 16, 2026 | 8.215 |
| June 15, 2026 | 8.426 |
| June 12, 2026 | 8.251 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Abeona Therapeutics, Inc. | 2.777 |
| ACADIA Pharmaceuticals, Inc. | 4.029 |
| Alnylam Pharmaceuticals, Inc. | 23.70 |
| Anika Therapeutics, Inc. | 2.098 |
| Savara, Inc. | 7.992 |
Price to Book Value Related Metrics
| PS Ratio | 6.494 |
| Price | 11.74 |
| Earnings Yield | -1.09% |
| Market Cap | 411.30M |